Supported by:
|
| National Heart, Lung, and Blood Institute |
| The National Heart, Lung, and Blood Institute (NHLBI) provides leadership for a national program in diseases of the heart, blood vessels, lung, and blood; blood resources; and sleep disorders. Since October 1997, the NHLBI has also had administrative responsibility for the NIH Woman's Health Initiative.
The Institute plans, conducts, fosters, and supports an integrated and coordinated program of basic research, clinical investigations and trials, observational studies, and demonstration and education projects. Research is related to the causes, prevention, diagnosis, and treatment of heart, blood vessel, lung, and blood diseases; and sleep disorders. The NHLBI plans and directs research in development and evaluation of interventions and devices related to prevention, treatment, and rehabilitation of patients suffering from such diseases and disorders. It also supports research on clinical use of blood and all aspects of the management of blood resources. Research is conducted in the Institute's own laboratories and by scientific institutions and individuals supported by research grants and contracts. |
| National Cancer Registrars Association |
| NCRA is a not-for-profit association representing cancer registry professionals and Certified Tumor Registrars(CTR). NCRA's primary focus is education and certification with the goal to ensure all Cancer Registry professionals have the required knowledge to be superior in their field. Worldwide, there are over 4,500 NCRA members and nearly 4,500 CTRs.
Cancer Registrars capture a complete summary of the history, diagnosis, treatment, & disease status for every cancer patient. Registrars' work leads to better information that is used in the management of cancer, and ultimately, cures. |
| National Cancer Institute |
| The National Cancer Institute's research programs are extensive and contain many innovative initiatives. I invite you to explore our Web site to find out more about the exciting work being conducted here at NCI and by NCI-supported scientists throughout the country.
You will also find valuable cancer-related information of all kinds. For the general public, patients, and health professionals, we offer consumer-oriented information on a wide range of topics as well as comprehensive descriptions of our research programs and clinical trials. Scientists will find detailed information on specific areas of research interest and funding opportunities. |
| Myelodysplastic Syndromes Foundation |
| The Myelodysplastic Syndromes Foundation was established by an international group of physicians and researchers to provide an ongoing exchange of information relating to MDS.
Until the Foundation was set up, no formal working group had been devoted to MDS. During the past decade we have conducted eight international symposia —in Austria, England, the United States, Spain, Czech Republic, Sweden, France, and Japan. The Ninth International Symposium is being held in May 2007 in Florence, Italy.
A major Foundation effort is our international information network. This network provides patients with referrals to Centers of Excellence, contact names for available clinical trials, sharing of new research and treatment options between physicians, and extension of educational support to both physicians and patients. |
| Multiple Myeloma Research Foundation |
| To date, the MMRF has raised more than $60 million to fund 51 laboratories worldwide. As good stewards of your funds, the MMRF is proud to channel 92% of dollars raised into supporting the most cutting-edge myeloma research worldwide. |
| Leukemia Research Fund |
| Leukaemia Research was established in 1960 and is still the only national research charity devoted exclusively to leukaemia, the lymphomas, myeloma, aplastic anaemia, myelodysplasia, the myeloproliferative disorders and the related blood disorders in both children and adults. |
| Leukemia & Lymphoma Society |
| The Leukemia & Lymphoma Society is the world's largest voluntary health organization dedicated to funding blood cancer research, education, and patient services. The Society's mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. |
|
|